Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for September 2004
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Recruitment replaces procurement as top concern, but PR sector optimistic
Industry survey points to upturn..(more)

 US antidepressant prescribing falls in under-18s
Safety concerns cause decline..(more)

 New report demands re-think on 48-hour access to GPs
Patient needs not being met..(more)

 NICE approval for Xigris
NICE guidance welcomed..(more)

 Hundreds vote in UK's Most Admired Pharma Company poll
Career Survey gathers momentum..(more)

 Children's NSF tackles off-label prescribing concerns
Eleven standards set out..(more)

 Pfizer's chronic pain drug launched in UK
Final FDA approval awaits..(more)

 Pfizer restricts UK supplies as US import battle escalates
Patient safety a motivation..(more)

 Yentreve launched in first European markets
Women the target market..(more)

 WPP acquires Grey for $1.5 billion
French group Havas lose out..(more)

 Major setback for AstraZeneca's Exanta
Liver side-effect major concern..(more)

 Schering and Bayer forge strategic partnership
Companies aim to improve fortunes..(more)

 Private firm to pioneer enhanced NHS cancer care
Integrated cancer care model the aim..(more)

 Schering pins hopes on new hormone therapy products
New products launched in US and Europe..(more)

 MPs' probing frustrated in pharma inquiry
MHRA defends drug safety record..(more)

 New centre to pave the way for European biotech success
New biotech centre to open in 2006..(more)

 Government backs UK biotech fundraising review
Marks & Spencer chairman involved..(more)

 Newly created Sanofi-Aventis buoyed by Acomplia
Plavix leads the way..(more)

 Barker takes ABPI reins as crunch time nears for PPRS
Renegotiation of PPRS top priority..(more)

 No food or drink restrictions for new HIV treatment
Telzir launched in UK..(more)

 Cymbalta launched amid renewed controversy
Wyeth's Efexor to be main rival..(more)

 Alarm raised over counterfeit Cialis
Counterfeit versions surface in UK..(more)

 GSK settles US antidepressant lawsuit with $2.5 million
Company maintains it did nothing wrong..(more)

 Online prescriptions given go-ahead as part of reforms
Patient access to be made easier ..(more)

 Sykes opens Chiltern's new global headquarters
Expansion continues in Europe..(more)

 Parexel forms clinical trial partnership with Doctors.net.uk
Parexel looks to expand clinical services..(more)

 Revolutionary Zocor Heart Pro gets off to a flying start
Sales exceed expectations..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.